Cellular immunity in Hodgkin's disease (Q41441728)

30 September 2017

title

Cellular immunity in Hodgkin's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A421176

30 June 2022

main subject

cell-mediated immunity

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A421176

30 June 2022

1 reference

10.1002/1097-0142(197902)43:2<492::AID-CNCR2820430214>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C492::AID-CNCR2820430214%3E3.0.CO;2-L

28 April 2023

author name string

S. H. Advani

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A421176

30 June 2022

H. D'Silva

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A421176

30 June 2022

B. P. Gothoskar

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A421176

30 June 2022

K. A. Dinshaw

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A421176

30 June 2022

C. N. Nair

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A421176

30 June 2022

R. Gopalkrishna

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A421176

30 June 2022

G. V. Talwalkar

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A421176

30 June 2022

P. B. Desai

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A421176

30 June 2022

language of work or name

English

0 references

publication date

1 February 1979

1 reference

full work available at URL

30 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197902)43:2%3C492::AID-CNCR2820430214%3E3.0.CO;2-L

1 reference

10.1002/1097-0142(197902)43:2<492::AID-CNCR2820430214>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C492::AID-CNCR2820430214%3E3.0.CO;2-L

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197902)43:2%3C492::AID-CNCR2820430214%3E3.0.CO;2-L

28 April 2023

1 reference

10.1002/1097-0142(197902)43:2<492::AID-CNCR2820430214>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C492::AID-CNCR2820430214%3E3.0.CO;2-L

28 April 2023

1 reference

30 September 2017

volume

43

1 reference

30 September 2017

issue

2

1 reference

30 September 2017

page(s)

492-499

1 reference

Correlation of delayed hypersensitivity and leukocyte migration inhibition factor in the serum of cancer patients

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197902%2943%3A2%3C492%3A%3AAID-CNCR2820430214%3E3.0.CO%3B2-L

Leukocyte migration studies in chronic myeloid leukemia (CML). Specificity of reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197902%2943%3A2%3C492%3A%3AAID-CNCR2820430214%3E3.0.CO%3B2-L

Levamisole and human lymphocyte cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197902%2943%3A2%3C492%3A%3AAID-CNCR2820430214%3E3.0.CO%3B2-L

Antibody formation in Hodgkin's disease

21 January 2018

1

1 reference

10.1002/1097-0142(197902)43:2<492::AID-CNCR2820430214>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C492::AID-CNCR2820430214%3E3.0.CO;2-L

Studies on delayed hypersensitivity in Hodgkin's disease

28 April 2023

2

1 reference

10.1002/1097-0142(197902)43:2<492::AID-CNCR2820430214>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C492::AID-CNCR2820430214%3E3.0.CO;2-L

Morphology and survival rates of cervical cancer in Connecticut and southwest England

28 April 2023

3

1 reference

10.1002/1097-0142(197902)43:2<492::AID-CNCR2820430214>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C492::AID-CNCR2820430214%3E3.0.CO;2-L

Circulating immune complexes and symptoms in Hodgkin's disease

28 April 2023

5

1 reference

10.1002/1097-0142(197902)43:2<492::AID-CNCR2820430214>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C492::AID-CNCR2820430214%3E3.0.CO;2-L

A standard method for DNCB sensitization testing in patients with neoplasms

28 April 2023

6

1 reference

10.1002/1097-0142(197902)43:2<492::AID-CNCR2820430214>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C492::AID-CNCR2820430214%3E3.0.CO;2-L

Quantitation of T and B lymphocytes and cellular immune function in Hodgkin's disease

28 April 2023

7

1 reference

10.1002/1097-0142(197902)43:2<492::AID-CNCR2820430214>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C492::AID-CNCR2820430214%3E3.0.CO;2-L

Hodgkin's disease. Immunologic, clinical, and histologic features of 50 untreated patients

28 April 2023

9

1 reference

10.1002/1097-0142(197902)43:2<492::AID-CNCR2820430214>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C492::AID-CNCR2820430214%3E3.0.CO;2-L

Comparison of multiple in vivo and in vitro parameters in untreated patients with Hodgkin's disease

28 April 2023

10

1 reference

10.1002/1097-0142(197902)43:2<492::AID-CNCR2820430214>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C492::AID-CNCR2820430214%3E3.0.CO;2-L

28 April 2023

12

31

1860

Carbone

1971

1 reference

10.1002/1097-0142(197902)43:2<492::AID-CNCR2820430214>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C492::AID-CNCR2820430214%3E3.0.CO;2-L

Second malignancies complicating Hodgkin's disease in remission

28 April 2023

13

1 reference

10.1002/1097-0142(197902)43:2<492::AID-CNCR2820430214>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C492::AID-CNCR2820430214%3E3.0.CO;2-L

28 April 2023

14

26

1097

Chase

1966

1 reference

10.1002/1097-0142(197902)43:2<492::AID-CNCR2820430214>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C492::AID-CNCR2820430214%3E3.0.CO;2-L

Long survival in Hodgkin's disease

28 April 2023

15

1 reference

10.1002/1097-0142(197902)43:2<492::AID-CNCR2820430214>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C492::AID-CNCR2820430214%3E3.0.CO;2-L

Serum migration-inhibitory activity in patients with lymphoproliferative diseases

28 April 2023

17

1 reference

10.1002/1097-0142(197902)43:2<492::AID-CNCR2820430214>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C492::AID-CNCR2820430214%3E3.0.CO;2-L

The New England Journal of Medicine

28 April 2023

18

289

863

Cohnen

1973

1 reference

10.1002/1097-0142(197902)43:2<492::AID-CNCR2820430214>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C492::AID-CNCR2820430214%3E3.0.CO;2-L

Immunological responsiveness against two primary antigens in untreated patients with Hodgkin's disease

28 April 2023

20

1 reference

10.1002/1097-0142(197902)43:2<492::AID-CNCR2820430214>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C492::AID-CNCR2820430214%3E3.0.CO;2-L

Inhibition of T-Cell Rosette Formation by Hodgkin-Disease Serum

28 April 2023

22

1 reference

10.1002/1097-0142(197902)43:2<492::AID-CNCR2820430214>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C492::AID-CNCR2820430214%3E3.0.CO;2-L

Quantitation of immunocompetence in Hodgkin's disease

28 April 2023

24

1 reference

10.1002/1097-0142(197902)43:2<492::AID-CNCR2820430214>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C492::AID-CNCR2820430214%3E3.0.CO;2-L

Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin's disease

28 April 2023

26

1 reference

10.1002/1097-0142(197902)43:2<492::AID-CNCR2820430214>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C492::AID-CNCR2820430214%3E3.0.CO;2-L

Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test

28 April 2023

27

1 reference

10.1002/1097-0142(197902)43:2<492::AID-CNCR2820430214>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C492::AID-CNCR2820430214%3E3.0.CO;2-L

Lymphocyte response to phytohemagglutinin in Hodgkin's disease

28 April 2023

29

1 reference

10.1002/1097-0142(197902)43:2<492::AID-CNCR2820430214>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C492::AID-CNCR2820430214%3E3.0.CO;2-L

Lymphocyte transformation changes during the clinical course of Hodgkin's disease

28 April 2023

30

1 reference

10.1002/1097-0142(197902)43:2<492::AID-CNCR2820430214>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C492::AID-CNCR2820430214%3E3.0.CO;2-L

Impaired lymphocyte function in untreated Hodgkin's disease.

28 April 2023

32

1 reference

10.1002/1097-0142(197902)43:2<492::AID-CNCR2820430214>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C492::AID-CNCR2820430214%3E3.0.CO;2-L

In Vitro Splenic IgG Synthesis in Hodgkin's Disease

28 April 2023

33

1 reference

10.1002/1097-0142(197902)43:2<492::AID-CNCR2820430214>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C492::AID-CNCR2820430214%3E3.0.CO;2-L

The New England Journal of Medicine

28 April 2023

35

296

1172

Morez

1977

1 reference

10.1002/1097-0142(197902)43:2<492::AID-CNCR2820430214>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C492::AID-CNCR2820430214%3E3.0.CO;2-L

Effect of Levamisole on E-Rosette-Forming Cells in Vivo and in Vitro in Hodgkin's Disease

28 April 2023

37

1 reference

10.1002/1097-0142(197902)43:2<492::AID-CNCR2820430214>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C492::AID-CNCR2820430214%3E3.0.CO;2-L

Cutaneous anergy and Hodgkin's disease

28 April 2023

39

1 reference

10.1002/1097-0142(197902)43:2<492::AID-CNCR2820430214>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C492::AID-CNCR2820430214%3E3.0.CO;2-L

28 April 2023

41

34

1178

Sutherland

1974

1 reference

10.1002/1097-0142(197902)43:2<492::AID-CNCR2820430214>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C492::AID-CNCR2820430214%3E3.0.CO;2-L

The persistence of Hodgkin's disease in long-term survivors

28 April 2023

42

1 reference

10.1002/1097-0142(197902)43:2<492::AID-CNCR2820430214>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C492::AID-CNCR2820430214%3E3.0.CO;2-L

Hodgkin's disease. An immunodepleting and immunosuppressive disorder

28 April 2023

43

1 reference

10.1002/1097-0142(197902)43:2<492::AID-CNCR2820430214>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C492::AID-CNCR2820430214%3E3.0.CO;2-L

The effect of levamisole on lymphocyte protein synthesis in vitro

28 April 2023

44

1 reference

10.1002/1097-0142(197902)43:2<492::AID-CNCR2820430214>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C492::AID-CNCR2820430214%3E3.0.CO;2-L

28 April 2023

Identifiers

10.1002/1097-0142(197902)43:2<492::AID-CNCR2820430214>3.0.CO;2-L

1 reference

30 September 2017

1 reference